SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS

NCT07562568 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
MDS
Transplantation, Stem Cell
Conditioning Therapy
SHR2554
Azacytidine

Interventions

COMBINATION_PRODUCT: SHR2554/AZA + Overlapped TBF
DRUG: mBUCY conditioning regimen

Sponsor

The First Affiliated Hospital of Soochow University